Increased risk of nausea and vomiting after first trimester is seen in women who are less well educated, have lower incomes, and more likely in black women.
↑Hesketh, Paul J.; Aapro, Matti; Street, James C.; Carides, Alexandra D. (2009). "Evaluation of risk factors predictive of nausea and vomiting with current standard-of-care antiemetic treatment: analysis of two phase III trials of aprepitant in patients receiving cisplatin-based chemotherapy". Supportive Care in Cancer. 18 (9): 1171–1177. doi:10.1007/s00520-009-0737-9. ISSN0941-4355.